The tragic cases of dedicated healthcare workers like Lorna Breen, Matt Gall, Mo Brown, Scott Jolley, William West Jr., and Tristin Smith are harrowing indicators of a disturbing trend: the skyrocketing rates of suicide among professionals in the medical field. These examples are just the tip of the iceberg, reflecting an ongoing crisis that extends
Health
Primary biliary cholangitis (PBC) is a chronic and progressive liver disease characterized by the autoimmune destruction of bile ducts within the liver, leading to cholestasis and the potential for severe liver damage. The management of PBC underwent a significant transformation with the approval of ursodeoxycholic acid (UDCA) in 1997, a development that brought hope to
Recent clinical trials have revived hope for patients suffering from moderately to severely active Crohn’s disease, particularly those who have previously failed standard therapeutic options. The latest phase III randomized trial results have generated significant interest in mirikizumab, a humanized monoclonal antibody targeting the p19 subunit of interleukin (IL)-23. Approved primarily for ulcerative colitis treatment,
Recent findings from France have shed light on the relationship between the consumption of ultraprocessed foods and psoriasis disease activity. This emerging link has garnered significant interest not only within the dermatological community but also among public health officials who are keen on understanding dietary impacts on chronic conditions. The NutriNet-Santé study, a large-scale cohort
On a recent Tuesday, the Centers for Medicare & Medicaid Services (CMS) unveiled a pivotal proposed rule aimed at improving transparency concerning prior authorization rules and coverage criteria within Medicare Advantage plans. This initiative, framed by the Biden-Harris administration as part of an ongoing effort to reform Medicare Advantage (MA) policies, seeks to ensure that
Meningiomas, classified as tumors arising from the protective meninges surrounding the brain and spinal cord, are often associated with significant clinical challenges due to their complex vascularization and diverse manifestations. The standard treatment strategy for these tumors typically involves surgical intervention. In recent years, however, preoperative embolization has garnered attention as a potentially beneficial adjunct
Healthcare, a multifaceted and ever-evolving field, often finds itself at the crossroads of regulatory challenges, clinical practice innovations, and the integration of technology. A recent FDA advisory committee meeting highlighted various perspectives from experts navigating these intricate dynamics, providing a valuable lens through which we can better understand the current healthcare landscape. At the forefront
As the political landscape continues to evolve under President-elect Donald Trump’s administration, the recent nominations for crucial healthcare leadership roles have sparked numerous discussions and concerns. The nomination of former Republican Congressman Dave Weldon, MD, for the position of Director of the Centers for Disease Control and Prevention (CDC) and Fox News contributor Janette Nesheiwat,
In an unexpected move, President-elect Donald Trump has announced his selection of Dr. Marty Makary to lead the Food and Drug Administration (FDA). With a background as a renowned surgical oncologist at Johns Hopkins University and a health policy expert, Makary’s nomination represents a significant shift in focus for the FDA. Trump recently expressed the
Chronic pain is an affliction that has increasingly come into focus amid ongoing public health discussions. A recent survey conducted by the Centers for Disease Control and Prevention (CDC) has brought to light sobering statistics regarding its prevalence within the U.S. adult population. According to new findings revealed by Jacqueline Lucas, MPH, and Inderbir Sohi,